Oncotype DX Recur Score - Invasive (Breast)

Note 1 Physician statement of Oncotype Dx Recurrence Score-Invasive score can be used to code this data item.

Note 2 The Oncotype Dx-Invasive recurrence score is reported as a whole number between 0 and 100. The actual recurrence score takes priority over codes XX4 and XX5.

Note 3 Record only the results of an Oncotype Dx-Invasive recurrence score in this data item. If some other test is used for scoring, assign code XX9.

Note 4 Predicted Oncotype Dx Recurrence Score based on linear regression models and Magee equations should not be reported in this field.

• If the only information you have on Oncotype Dx is based on a linear regression model and Magee score, code unknown
• Code the results of a Magee score in the Multigene Data Items Multigene Signature Method (NAACCR Data Item #3894) and Multigene Signature Results (NAACCR Data Item #3895)

Note 5 In cases where Oncotype DX is reported on more than one breast tumor specimen, record the highest value.

Note 6 Results from nodal or metastatic tissue may be used, ONLY when there is no evidence of primary tumor.

Note 7 Staging for Breast cancer now depends on the Oncotype-Dx-Invasive recurrence score. Score of less than 11 indicates a pertinent cut off value for staging purposes.

Note 8 If the only information available is the Oncotype Dx-Invasive Risk Level, assign XX7.

Note 9 Code this data item using the same report used to record Oncotype Dx Risk Level-Invasive (NAACCR Data Item #3906)